ATHENA NEUROSCIENCES FILES IND FOR TIZANIDINE PHASE III TRIAL, EXTENDS LILLY ALZHEIMER's RESEARCH PACT ON EVE OF $ 35 MIL. INITIAL PUBLIC OFFERING